Hummer Financial Advisory Services’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,142
Closed -$228K 89
2022
Q2
$228K Hold
4,142
0.26% 84
2022
Q1
$228K Buy
4,142
+400
+11% +$21.7K 0.21% 95
2021
Q4
$209K Sell
3,742
-400
-10% -$20.8K 0.18% 101
2021
Q3
$201K Hold
4,142
0.19% 104
2021
Q2
$209K Buy
+4,142
New +$199K 0.19% 103
2020
Q3
Sell
-4,382
Closed -$227K 95
2020
Q2
$227K Buy
4,382
+160
+4% +$8.21K 0.29% 79
2020
Q1
$203K Buy
4,222
+328
+8% +$17.5K 0.31% 79
2019
Q4
$231K Buy
+3,894
New +$217K 0.25% 93

Other funds holding GSK

Hummer Financial Advisory Services's GSK Position: Q3 2022 in Review

Hummer Financial Advisory Services sold out of GSK (GSK) in Q3 2022, closing a stake of 4,142 shares — an estimated $228K sold.

Hummer Financial Advisory Services first reported a position in GSK in Q4 2019 and held it in 8 quarters. The position peaked at $231K in Q4 2019. 743 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Hummer Financial Advisory Services reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Hummer Financial Advisory Services sold 4,142 GSK shares in Q3 2022, an estimated $228K.
  • Hummer Financial Advisory Services first reported a position in GSK in Q4 2019 and held it in 8 quarters.
  • Hummer Financial Advisory Services's GSK position peaked at $231K in Q4 2019.
  • 743 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Hummer Financial Advisory Services's 13F filing for Q3 2022, filed 12 Oct 2022.